Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,523 | -26,095 | -12,472 | -39,355 | -25,205 |
| Depreciation Amortization | 1,585 | 1,024 | 505 | 1,493 | 1,036 |
| Other Working Capital | -889 | -312 | -857 | -5,491 | -3,215 |
| Other Operating Activity | 6,048 | 4,078 | 1,974 | 6,490 | 4,819 |
| Operating Cash Flow | $-32,779 | $-21,305 | $-10,850 | $-36,863 | $-22,565 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,821 | 7,993 | 6,946 | 24,413 | 599 |
| PPE Investments | -1,724 | -1,440 | -665 | -2,667 | -1,663 |
| Investing Cash Flow | $22,097 | $6,553 | $6,281 | $21,746 | $-1,064 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,758 | 2,855 | N/A | N/A | N/A |
| Debt Repayment | -710 | -427 | -276 | -1,528 | -1,148 |
| Common Stock Issued | 48 | 11 | 14 | 530 | 444 |
| Financing Cash Flow | $3,096 | $2,439 | $-262 | $-998 | $-704 |
| Beginning Cash Position | 28,073 | 28,073 | 28,073 | 44,188 | 44,188 |
| End Cash Position | 20,487 | 15,760 | 23,242 | 28,073 | 19,855 |
| Net Cash Flow | $-7,586 | $-12,313 | $-4,831 | $-16,115 | $-24,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,779 | -21,305 | -10,850 | -36,863 | -22,565 |
| Capital Expenditure | -1,724 | -1,440 | -665 | -2,667 | -1,663 |
| Free Cash Flow | -34,503 | -22,745 | -11,515 | -39,530 | -24,228 |